Brain disorders cost Europe €800bn a yearBMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d6370 (Published 04 October 2011) Cite this as: BMJ 2011;343:d6370
- Ingrid Torjesen
Europe spends more on brain disorders than on cardiovascular disease and cancer combined, a comprehensive study commissioned by the European Brain Council has found.
The study, published in European Neuropsychopharmacology (doi:10.1016/j.euroneuro.2011.08.008), found that Europe spends €798bn (£685bn; $1060bn) a year on neurological and psychiatric conditions, €192bn on cardiovascular disease, and €150-250bn on cancer. The total costs comprised direct costs, such as treatment, and indirect costs, such as the cost of sickness absence.
The most costly group of brain disorders was mood disorders, including major depression and bipolar disorders (€113bn a year) and dementia (€105bn).
The researchers, who came from across Europe, used existing prevalence and economic data to estimate the costs of 19 groups of brain disorders in 30 European countries …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial